neurosurgical focus
C ushing syndrome was first described and characterized in a series of 10 patients by Dr. Harvey Cushing in 1932. 4 Since that time, our understanding of the disease, especially its varied etiologies and diagnostic criteria, has been continuously refined. We now understand that Cushing syndrome is caused by the overproduction of cortisol, and its symptoms are manifestations of prolonged hypercortisolemia. 27 Common signs and symptoms include central obesity, rapid weight gain, proximal muscle weakness, hypertension, irritability, diabetes mellitus, easy bruising, abdominal striae, moon facies, dorsocervical fat deposition, and acne. 28 Cushing disease is caused by an adrenocorticotropic hormone (ACTH)-producing pituitary adenoma that stimulates excess cortisol production by the adrenal glands and is the most common cause of Cushing syndrome. 2, 13 Although most cases of Cushing syndrome are caused by an ACTH pituitary adenoma, a pituitary adenoma can be "ectopic" (i.e., it can occur outside of the sella turcica without any direct connection to the pituitary gland). 40 Ectopic pituitary adenomas are rare lesions; fewer than 100 cases were reported over the past century. We report here the case of a patient with Cushing syndrome and an ectopic ACTH-secreting pituitary adenoma confined to the sphenoid sinus. In addition, a systematic literature review was performed to identify previous cases of ectopic ACTH-secreting pituitary adenomas; the clinical presentations, treatments, findings, and postoperative courses of these patients presenting with ectopic ACTH adenomas are discussed in this review.
methods overview of systematic literature review
A systematic literature review was performed to find all published cases of ectopic ACTH pituitary adenomas regardless of anatomical location. A subanalysis of these articles focused on cases of ectopic ACTH adenomas arising within the sphenoid sinus.
search strategy and terms
A search for all ectopic ACTH pituitary adenomas was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria and using the PubMed database with the string "ectopic pituitary" to capture the large number of title variations present. This same strategy was applied to the search for ectopic ACTH adenomas of the sphenoid sinus. For this search, the string (("ectopic pituitary") AND ("sphenoid")) was used in PubMed. The 2 searches were performed separately to decrease the possibility of missed cases.
inclusion/exclusion criteria
For the general search for articles pertaining to ectopic ACTH pituitary adenomas, the inclusion criteria were functional ACTH secretion, ectopic location without communication with the pituitary gland, pathologically verified pituitary adenoma, and case report or case series presentation. The rejection criteria included incorrect tumor type, non-English-language articles, nonspecific or combined case data, and no or incomplete outcome results. Full articles were predominantly used to determine inclusion and exclusion; however, abstracts were used for screening when the full article was not available. The search for and subanalysis of ectopic ACTH adenoma of the sphenoid sinus involved the same exclusion criteria as the general search. The inclusion criteria also remained nearly the same; the only modification was the specific location within the sphenoid sinus.
case report history
A 48-year-old man presented with symptoms and signs of Cushing syndrome, including hypertension, diabetes mellitus, memory dysfunction, proximal muscle weakness, easy bruisability, anxiety, and insomnia for 2 months before evaluation in our clinic. He developed rapidly progressive diabetes mellitus and electrolyte abnormalities over the 30-day period before diagnosis.
Laboratory results showed a morning serum cortisol level of 51 μg/dl (reference range 4-22 μg/dl) and an ACTH level of 195.7 pg/ml (reference range 6-50 pg/ml). His urinary free cortisol level was 2109 μg/day (reference range 4-50 μg/day). The test results also revealed hypocalcemia, hyperglycemia, and hypogonadotropic hypogonadism. The patient was diagnosed with Cushing syndrome, treated with 200 mg of oral ketoconazole 3 times daily, and referred for a neurosurgical consultation.
examination
Evaluation of the patient in our clinic showed that he was obese (body mass index 41.5 kg/m 2 ) and hypertensive (blood pressure 165/105 mm Hg) despite receiving daily atenolol, lisinopril, and spironolactone therapy. The patient did not have many classical cushingoid features, likely because of the rapid onset of symptoms. Bilateral proximal lower-extremity weakness (Grade 4/5) with tremor, gait disturbances, and 1+ pitting edema were noted. The patient reported frequent nocturia and heat intolerance.
Further endocrine testing revealed a serum cortisol level of 48 μg/dl after the administration of 8 mg of dexamethasone. MRI with and without Gd (Fig. 1) showed a 5-mm nonenhancing mass in the left inferior pituitary gland and a 1.8-cm enhancing mass on T1-weighted imaging, low signal intensity on T2-weighted imaging in the right superior sphenoid sinus, and complete separation from the sella turcica and pituitary gland. CT scans of the thorax, abdomen, and pelvis were negative for any masses.
A diagnosis of ACTH-dependent Cushing syndrome with a central source was made on the basis of the MRI findings and the negative CT results. Inferior petrosal sinus sampling was deferred because of unclear additional clinical benefit in the presence of the 2 masses in the sphenoid sinus and sella. Our decision to pursue surgery directly was informed by the high likelihood of at least 1 of the 2 identified masses being the root cause and by the fact that both masses could be resected during the same procedure. In addition, the low signal intensity of the sphenoid sinus mass on T2-weighted imaging helped distinguish it from sphenoid sinus disease and further informed our clinical decision making.
operation
An endoscopic endonasal transsphenoidal approach was taken to provide the greatest access to both the sphenoid sinus and the left sellar mass with the lowest risk to the patient. The patient's nasal cavity and right lower quadrant were prepared. Neuronavigation was then calibrated for use throughout the procedure. A 0° endoscope was used to identify and lateralize the middle turbinates. The sphenoid ostia were then identified, cauterized, and widened. The nasal septum was then injected with lidocaine/epinephrine and incised vertically at the junction of the bony and cartilaginous septum. Bilateral nasal-mucosal flaps were developed, and the vomer was then removed using rongeurs. The anterior sphenoidotomy was widened by removing the sphenoid rostrum in a circumferential fashion.
After entry into the sphenoid sinus, a large mass was identified superiorly in the right sphenoid sinus (Fig. 2) . The tumor was grossly removed using suction, tumor forceps, and ring curettes. This process resulted in a small CSF leak located in the posterior ethmoid roof along the skull base that was subsequently repaired using autologous fascia and fat from the patient's abdomen.
After gross-total resection of the sphenoid sinus mass, the bony floor of the sella was identified and removed using a Kerrison rongeur. Neuronavigation and micro-Dop- pler were then used to confirm the location of the bilateral internal carotid arteries. Once safe margins were established, the dura was incised and the sellar contents were exposed. The second mass, located in the left aspect of the pituitary gland, was then identified and removed entirely by using ring curettes. The pituitary gland was preserved, and no intrasellar CSF leak was noted.
After resection of both lesions, a CSF leak repair of the ethmoidal skull base defect was performed by using a small amount of subcutaneous fat and abdominal fascia harvested from the right lower quadrant of the patient's abdomen. The fascia and fat were placed within the fovea ethmoidalis and covered with a layer of DuraGen collagen matrix. Successive layers of Surgicel absorbable cellulose hemostat and DuraSeal hydrogel were placed over the layer of DuraGen. The middle turbinate was then medialized to provide additional structural support. A small piece of fat was placed within the resection cavity of the sella turcica to obliterate the dead space in this region.
Once the repair was completed, the nasal cavity and nasopharynx were suctioned, Merocel nasal packs were inserted, and a lumbar drain was inserted at L4-5. The patient was then extubated and brought to the neurological intensive care unit in stable condition.
pathological Findings
The sphenoid sinus tumor and the pituitary tumor were submitted separately to pathology and processed routinely to create H & E-stained sections (Figs. 3 and 4). Both specimens were also stained for pituitary hormones, alpha subunit, and CAM5.2 (a low-molecular-weight cytokeratin) by standard immunohistochemical techniques. The sphenoid sinus tumor was also immunohistochemically stained for synaptophysin, chromogranin A, and proliferation-associated antigen Ki-67 (MIB-1).
The sphenoid sinus tumor stained positively for synaptophysin, CAM5.2, and ACTH (Fig. 5) . Results of the stains for the other pituitary hormones, alpha subunit, and chromogranin A were negative. The percentage of nuclei positive for MIB-1 was less than 3%.
The pituitary tumor specimen consisted of 3 small tissue fragments. Two of them were fibrotic anterior pituitary tissue, which was confirmed by immunohistochemistry to be positive for all the pituitary hormones and alpha subunit. These fragments contained scattered cells showing Crooke hyaline changes with no evidence of pituitary adenoma. The third fragment appeared to consist of fibrous tissue and numerous cells showing Crooke hyaline changes but tested negative for all pituitary hormones except for ACTH, which appeared in a few cells. It has been reported, and is our experience, that better-developed Crooke hyaline changes stain less for ACTH.
postoperative course
The patient had a relatively benign postoperative course. Daily morning cortisol levels on the first 4 days after the operation were 13.2, 9.5, 10.5, and 18.1 μg/dl (ref- erence range 4.6-20.6 μg/dl) ( Table 1) . Despite elevated postoperative cortisol levels, the patient was believed, on the basis of clinical symptoms of headache, nausea, vomiting, and fatigue, to have secondary adrenal insufficiency. He was started on 25-mg twice-daily oral hydrocortisone replacement therapy. No evidence of diabetes insipidus was found. The patient was discharged 5 days after the operation.
The patient improved over the next several weeks, with rapid regression of his symptoms and signs of Cushing syndrome. His blood pressure and diabetes medications were discontinued within 1 month of surgery, and hydrocortisone replacement was discontinued 3 months after the operation. Roughly 1 month after surgery, the patient developed new-onset sinus tachycardia that was controlled with medication. He developed sinusitis requiring antibiotics and evaluation by an otolaryngologist 3 months after surgery. Follow-up MRI 8 weeks after surgery revealed gross-total resection, and the patient was cleared to return to work at that time. At the 6-month endocrinology follow-up, clinical remission of his symptoms was noted. Laboratory testing revealed a urinary free cortisol level of 14 μg/day (reference range 11-84 μg/day). At the 10-month neurosurgical follow-up, on the basis of serum morning cortisol levels and no evidence of tumor recurrence on MRI (Fig. 6) , the patient remained in hormonal remission. The most recent endocrinology follow-up, 11 months after the operation, confirmed clinical remission (resolution of the diabetes mellitus, joint pain, and muscle weakness and a urinary free cortisol level of 19 μg/day [reference range 11-84 μg/day]).
results literature review

Ectopic ACTH Adenomas Arising Within the Sphenoid Sinus
The search yielded 84 results, of which 47 were analyzed on the basis of relevancy. Fourteen cases were selected on the basis of the inclusion/exclusion criteria. Four additional cases, from Pluta et al., 31 Morita et al., 25 Srikantha et al., 36 and Ritter et al., 32 were found outside of the search; the Pluta et al. case was located within a mixed Nineteen cases, including our own, were included in the following focused review and analysis.
Patient ages ranged from 16 to 76 years, and there were 15 women and 4 men. For 13 of the 19 cases, the sizes of the resected masses were reported; the mean was 13.9 mm and the median was 8 mm (range 3-55 mm). Seven were microadenomas (< 1 cm). The appearance on gross examination was consistently described as polypoid. Most were described as covered by sinus mucosa. No sellar or cavernous sinus invasion was noted, although Coire et al. 8 described a thinning of the anterior sellar wall in 1 case. For the 15 cases that reported a serum ACTH level, the mean was 106.7 pg/ml. The lowest preoperative ACTH level reported was used for this average when specific morning ACTH measurements were not noted. Four reports did not include serum ACTH measurements. For 10 cases serum morning cortisol levels were reported, the mean of which was 32.5 μg/dl. Four cortisol measurements were excluded on the basis of inappropriate reporting or unknown timing, and 5 articles did not report serum cortisol levels.
Gross-total resection was achieved for all but 1 patient, and full and durable hormonal remission of Cushing syndrome was achieved for all of them. For the 13 for whom follow-up times were reported, the mean was 20 months. No significant complications were noted. Twelve patients required postoperative hydrocortisone supplementation. Two patients underwent bilateral adrenalectomy, which resulted in 1 case of Nelson syndrome. Two patients were treated with hemihypophysectomy. One had a total hypophysectomy, resulting in panhypopituitarism that was treated with hormone replacement. One patient had a partial resection that resulted in persistently elevated ACTH and serum cortisol levels, but these levels were found to be responsive to dexamethasone suppression and no further treatment was noted. One patient had a recurrent adenoma and was treated successfully with external-beam radiation therapy.
All Ectopic ACTH Adenomas
The search yielded 233 results, of which 77 results were analyzed. After application of the inclusion/exclusion cri- teria, 38 cases of ectopic ACTH-producing pituitary adenomas were included in this review. Including the 3 cases found outside of the search (noted above) and our own case, a total of 42 cases are summarized in Tables 2 and 3 .
discussion
Most patients diagnosed with Cushing syndrome will subsequently be found to have Cushing disease, the result of a central ACTH-secreting pituitary adenoma. The remainder of the patients will have ACTH-dependent disease from an ectopic source or a non-ACTH-dependent subtype. True ectopic pituitary adenomas are rare clinical-pathological entities, and their development, behavior, and biochemical profile are still largely undetermined. For example, our patient presented with high-dose dexamethasone-suppression test results mostly consistent with an ectopic (i.e., nonpituitary) source. Given that the cause was a functional pituitary adenoma, this result appears to be inconsistent with the known feedback-inhibition pattern found in functional ACTH-secreting pituitary adenomas. Suzuki et al. 37 performed a literature review and found a variable response to dexamethasone suppression in multiple other cases. It is likely that these tumors behave differently than central adenomas in terms of glucocorticoid suppression.
We report here the 19th known ACTH-producing ectopic pituitary adenoma arising purely in the sphenoid sinus. Although their exact origin is unknown, it is thought that ectopic pituitary adenomas arise from remnants of the Rathke pouch during its developmental course. Because of this common origin with normal pituitary tissue, adenomas that form from this ectopic tissue often retain the same general features and functional variability as normal pituitary adenomas. 22 These tumors, therefore, can be found purely within the nasopharynx, sphenoid sinus, cavernous sinus, clivus, or suprasellar region. 16, 22 Suprasellar origins in the third ventricle, hypothalamus, and interpeduncular cistern without any sellar communication have been reported. It is not definitively known what factors influence their location or contribute to the formation of ectopic pituitary adenomas. 3 Given the diversity of locations and adenoma sizes, otherwise standard stepwise investigations into the underlying cause of clinically diagnosed Cushing syndrome can be frustrated by an occult ectopic adenoma. Failure to locate an ectopic ACTH-secreting adenoma promptly can result in the use of permanently destructive or ablative procedures such as bilateral adrenalectomy and hypophysectomy. Bilateral adrenalectomy remains a viable treatment option for those with refractory Cushing syndrome despite the risk of it causing Nelson syndrome. 14, 31 Given the high mortality rate for those with nonpituitary Cushing syndrome (44% at 10 years, in stark contrast to just 3% with Cushing disease), 30 the prompt identification and removal of a functioning ectopic pituitary adenoma is essential and can result in a rapid and durable remission. 18, 21 Given the severity of the disease, patients presenting with Cushing syndrome from an unknown source should always be evaluated for the possibility of an ectopic pituitary adenoma. These tumors are exceedingly rare; roughly 90 cases of all types of ectopic pituitary adenomas 17 have been reported since Erdheim published the first case in 1909. 10 Our literature review of all functional ACTH-secreting ectopic pituitary adenomas identified 34 published cases of functional ACTH-producing ectopic pituitary adenomas. This number, however, is in stark contrast to the thousands of ACTH-producing sellar pituitary adenomas diagnosed annually, comprising 10%-15% of all treated pituitary adenomas. 16 Because of the rarity of this condition, even experienced physicians may overlook the possibility of a functional ectopic pituitary adenoma as part of the differential diagnosis of Cushing syndrome. Similarly, an ectopic tumor location can lead to misdiagnosis. In our experience, ectopic tumors are most commonly mistaken for nasal or sinus polyps when found incidentally on a CT scan or noncontrast MRI. These misdiagnoses may result in delayed diagnosis and treatment, increased cost, and prolonged exposure to hypercortisolemia.
There are several limitations that may have constrained our review and report. On the basis of histopathology alone, it is impossible to be certain that the sphenoid sinus tumor arose from ectopic pituitary tissue. Although we believe, on the basis of clinical remission after resection and imaging/histopathological characteristics, that the sphenoid sinus tumor was in fact an ectopic pituitary adenoma, we cannot definitively prove this conclusion on the basis of the pathological analysis alone. Also, the current review was limited by the small number of patients included in the analysis and the susceptibility to publication bias. Nevertheless, ectopic ACTH adenomas are an important pathological entity of which neurosurgeons, endocrinologists, and other treating physicians should be mindful when evaluating patients with Cushing syndrome.
conclusions
With this case report, we sought not only to provide the most up-to-date comprehensive literature review of cases of ectopic ACTH-producing adenomas as a cause of Cushing syndrome, but also to provide a reminder to consider this rare condition when evaluating any patient with Cushing syndrome. Exploration of any suspicious sinus masses as a source of ectopic ACTH secretion is especially important after a standard stepwise work-up for patients with hypercortisolemia because of the very real possibility of misdiagnosing a more benign growth. Finally, clinicians should continue to investigate and publish diverse cases of ectopic pituitary adenomas so that the behavior of these unusual tumors can be better understood.
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